Semax
ACTH-derived synthetic peptide studied for BDNF/NGF upregulation, neuroprotection, and cognitive performance enhancement in rodent models. Administered intranasally in most studies. Developed in Russia; used clinically there for stroke recovery.
Lo que Muestra la Investigación
Studied for BDNF and NGF upregulation, cognitive enhancement, and neuroprotection via monoaminergic signalling enhancement. Studies measure hippocampal BDNF mRNA (qPCR), Morris Water Maze escape latency, and TrkB phosphorylation. Demonstrates 2–3× BDNF increase in published rodent studies; limited Western clinical trial data.
Pros y Contras
- +Nasal spray delivery — no injections required, lower barrier than most peptide categories
- +Selank shows anxiolytic potency comparable to benzodiazepines in animal models, without sedation or withdrawal
- +Semax demonstrates 2–3× increase in hippocampal BDNF in published rodent studies
- +Both compounds have been used clinically in Russia with decades of post-marketing observation
- +Fast onset for anxiolytic effects: animal models show reduced anxiety within 30–60 minutes of intranasal dosing
- +Cognitive and mood effects often reported together — broad neurological profile from two compounds
- −Most human trial data comes from Russian-language studies, many not available in peer-reviewed Western journals
- −Short half-life requires consistent twice-daily dosing — missed doses disrupt the protocol
- −Nasal absorption varies significantly between individuals based on mucosal health and dosing technique
- −No Western regulatory approval (FDA, EMA)
- −Limited LATAM-accessible vendor availability compared to healing peptides — stock issues are common
- −Subjective effects can be subtle; self-researchers report highly variable responses
Cronología de Efectos
Basado en cronologías de estudios publicados. La extrapolación humana es aproximada — los resultados individuales varían significativamente.
Anxiolytic effects of Selank are measurable within hours in animal models. BDNF protein increases from Semax are detectable at 24–72 hours post-dose in rodent studies. Self-researchers commonly report noticeable mood and focus effects within 3–7 days of consistent use.
Para Qué se Investiga
Preguntas Prácticas
How do I use a nasal spray for Semax or Selank correctly?
Dissolve the lyophilised peptide in sterile saline to 0.1% (1 mg/mL) in a clean nasal atomiser. Clear nasal passages first. Spray into one nostril while gently inhaling — this facilitates olfactory nerve transport. Alternate nostrils between doses. Store reconstituted solution at 4°C and use within 14 days. Note: pump atomisers (MAD Nasal style) deliver more consistent droplet size than squeeze bottles.
Can I use Semax and Selank together?
Self-researchers frequently combine them: Semax for cognitive enhancement and BDNF upregulation, Selank for anxiety reduction and GABAergic modulation. They work via different mechanisms with no known adverse interactions. A common protocol in the research community is Semax in the morning and Selank in the evening, though no human clinical data exists to validate this specific approach.
How quickly should I expect to notice effects, and how long do they last?
In animal studies, Selank's anxiolytic effects are measurable within the first hour. Semax BDNF upregulation builds over 24–72 hours. Many self-researchers report noticing mood and focus improvements within the first week of consistent daily use. Effects appear to require ongoing administration — they are not persistent after stopping, unlike some nootropics.
Dónde Comprar Semax en Latinoamérica
4 proveedores accesibles para LATAM tienen Semax actualmente disponible en stock, incluyendo 2 con envío verificado a LATAM. Compara precios y disponibilidad abajo.